Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$53.53 -2.6%	$55.00	$46.00 ▼ $78.19	$1.66B	1.24	443,773 shs	325,631 shs
GNGBY Getinge AB (publ)	$19.32 -2.4%	$19.39	$14.84 ▼ $22.85	$5.26B	1.1	26,895 shs	27,011 shs
INMD InMode	$13.36 -4.9%	$14.66	$13.28 ▼ $19.85	$844.47M	1.98	1.19 million shs	2.37 million shs
MASI Masimo	$161.20 -2.5%	$158.12	$101.61 ▼ $194.88	$8.74B	1.19	643,151 shs	547,190 shs

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	-2.37%	-5.99%	-8.34%	-9.13%	-26.98%
GNGBY Getinge AB (publ)	-2.37%	-1.13%	-1.18%	-11.87%	+10.27%
INMD InMode	-4.91%	-5.65%	-8.30%	-27.03%	-27.11%
MASI Masimo	-2.50%	-6.26%	+5.26%	-4.17%	+21.58%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CNMD CONMED	4.4536 of 5 stars	2.1	2.0	2.5	4.3	2.9	0.8	3.1
GNGBY Getinge AB (publ)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INMD InMode	3.7403 of 5 stars	4.1	3.0	0.0	0.0	2.7	1.7	1.9
MASI Masimo	4.117 of 5 stars	3.4	1.0	0.0	4.2	1.5	3.3	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNMD CONMED	2.20	Hold	$62.20	16.20% Upside
GNGBY Getinge AB (publ)	0.00	N/A	N/A	N/A
INMD InMode	2.13	Hold	$18.54	38.78% Upside
MASI Masimo	2.83	Moderate Buy	$191.60	18.86% Upside

Current Analyst Ratings Breakdown

Latest GNGBY, MASI, INMD, and CNMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/12/2025	CNMD CONMED	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$61.00
5/7/2025	MASI Masimo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$193.00
5/7/2025	MASI Masimo	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $200.00
5/7/2025	MASI Masimo	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$204.00 ➝ $185.00
5/7/2025	MASI Masimo	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $190.00
5/1/2025	CNMD CONMED	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$70.00 ➝ $58.00
5/1/2025	CNMD CONMED	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$70.00 ➝ $57.00
5/1/2025	CNMD CONMED	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$91.00 ➝ $61.00
4/30/2025	INMD InMode	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$29.00 ➝ $24.00
4/29/2025	INMD InMode	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$19.00 ➝ $16.25
4/29/2025	INMD InMode	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$17.00 ➝ $15.00

(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNMD CONMED	$1.32B	1.26	$5.86 per share	9.13	$31.15 per share	1.72
GNGBY Getinge AB (publ)	$3.29B	1.60	$1.52 per share	12.72	$10.53 per share	1.83
INMD InMode	$392.41M	2.15	$1.28 per share	10.40	$10.12 per share	1.32
MASI Masimo	$2.13B	4.11	$5.24 per share	30.74	$25.79 per share	6.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNMD CONMED	$132.42M	$3.80	12.63	10.56	1.83	10.13%	14.31%	5.64%	7/30/2025 (Estimated)
GNGBY Getinge AB (publ)	$154.96M	$0.51	33.89	∞	N/A	4.71%	9.84%	5.36%	7/18/2025 (Estimated)
INMD InMode	$181.27M	$2.33	5.69	7.34	N/A	45.91%	18.25%	16.33%	7/30/2025 (Estimated)
MASI Masimo	$81.50M	-$9.17	111.17	34.82	N/A	3.85%	14.98%	6.95%	8/5/2025 (Estimated)

Latest GNGBY, MASI, INMD, and CNMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/6/2025	Q1 2025	MASI Masimo	$1.24	$1.36	+$0.12	-$3.12	$367.79 million	$372.00 million
4/30/2025	Q1 2025	CNMD CONMED	$0.81	$0.95	+$0.14	$0.19	$313.38 million	$321.26 million
4/28/2025	Q1 2025	INMD InMode	$0.45	$0.31	-$0.14	$0.26	$82.21 million	$77.87 million
4/22/2025	Q1 2025	GNGBY Getinge AB (publ)	N/A	$0.20	N/A	$0.10	N/A	$779.56 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNMD CONMED	$0.80	1.49%	N/A	21.05%	N/A
GNGBY Getinge AB (publ)	$0.28	1.45%	N/A	54.90%	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A

Latest GNGBY, MASI, INMD, and CNMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	CNMD CONMED	quarterly	$0.20	1.34%	6/13/2025	6/13/2025	7/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNMD CONMED	0.94	2.30	1.06
GNGBY Getinge AB (publ)	0.06	0.78	0.50
INMD InMode	N/A	10.23	9.38
MASI Masimo	0.50	2.01	1.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNMD CONMED	N/A
GNGBY Getinge AB (publ)	N/A
INMD InMode	68.04%
MASI Masimo	85.96%

Insider Ownership

Company	Insider Ownership
CNMD CONMED	3.10%
GNGBY Getinge AB (publ)	N/A
INMD InMode	6.92%
MASI Masimo	16.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNMD CONMED	4,100	30.94 million	28.81 million	Optionable
GNGBY Getinge AB (publ)	11,386	272.37 million	N/A	Not Optionable
INMD InMode	480	63.21 million	64.75 million	Optionable
MASI Masimo	6,200	54.22 million	48.35 million	Optionable

GNGBY, MASI, INMD, and CNMD Headlines

Recent News About These Companies

Masimo COO Departs Amid Leadership Shakeup

June 14 at 2:50 AM | marketwatch.com

Masimo COO to Resign

June 14 at 2:50 AM | ocbj.com

Masimo Announces Key Leadership Changes in June 2025

June 12 at 5:24 PM | tipranks.com

Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years

June 12 at 12:40 PM | benzinga.com

MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties

June 10, 2025 | globenewswire.com

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

June 10, 2025 | finance.yahoo.com

Research: Masimo SedLine Enhances Pediatric Anesthesia

June 10, 2025 | miragenews.com

New Masimo CEO Katie Szyman Reveals Personal Ties to Device Maker

June 10, 2025 | ocbj.com

Study backs Masimo brain monitoring tech during pediatric anesthesia

June 10, 2025 | massdevice.com

3 Reasons MASI is Risky and 1 Stock to Buy Instead

June 9, 2025 | msn.com

Rhumbline Advisers Lowers Holdings in Masimo Co. (NASDAQ:MASI)

June 7, 2025 | marketbeat.com

Masimo Co. (NASDAQ:MASI) Holdings Boosted by RFG Advisory LLC

June 6, 2025 | marketbeat.com

GAMMA Investing LLC Purchases 122,485 Shares of Masimo Co. (NASDAQ:MASI)

June 6, 2025 | marketbeat.com

Masimo Co. (NASDAQ:MASI) Short Interest Up 17.4% in May

June 5, 2025 | marketbeat.com

Two Sigma Advisers LP Cuts Holdings in Masimo Co. (NASDAQ:MASI)

June 3, 2025 | marketbeat.com

Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today

June 2, 2025 | benzinga.com

Masimo’s Strategic Growth and Resilience: Analyst Recommends Buy Rating

June 1, 2025 | tipranks.com

Cetera Investment Advisers Buys Shares of 1,846 Masimo Co. (NASDAQ:MASI)

June 1, 2025 | marketbeat.com

Masimo Co. (NASDAQ:MASI) Receives Average Recommendation of "Moderate Buy" from Analysts

June 1, 2025 | marketbeat.com

Masimo (NASDAQ:MASI) Lowered to Hold Rating by Wall Street Zen

June 1, 2025 | marketbeat.com

Zacks Research Has Pessimistic Outlook of Masimo Q2 Earnings

May 31, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GNGBY, MASI, INMD, and CNMD Company Descriptions

CONMED NYSE:CNMD

$53.53 -1.44 (-2.62%)

Closing price 06/13/2025 03:59 PM Eastern

Extended Trading

$53.54 +0.01 (+0.02%)

As of 06/13/2025 04:10 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Getinge AB (publ) OTCMKTS:GNGBY

$19.32 -0.47 (-2.37%)

As of 06/13/2025 03:59 PM Eastern

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

InMode NASDAQ:INMD

$13.36 -0.69 (-4.91%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$13.43 +0.07 (+0.52%)

As of 06/13/2025 07:47 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Masimo NASDAQ:MASI

$161.20 -4.14 (-2.50%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$159.02 -2.17 (-1.35%)

As of 06/13/2025 07:44 PM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time